Utama › Kanser Ovari › Virginia › Arlington
Kajian klinikal Kanser Ovari di Arlington, VA
46 kajian untuk Kanser Ovari sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- NEXT Virginia, Fairfax · 11 mi jauh
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Mengambil pesertaFasa 2
- Next Virginia /ID# 279684, Fairfax · 11 mi jauh
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Mengambil pesertaFasa 1
- Next Virginia /ID# 278607, Fairfax · 11 mi jauh
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
- Site 04, Fairfax · 11 mi jauh
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Mengambil pesertaFasa 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Mengambil pesertaFasa 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi jauh
Study of AVZO-021 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Mengambil pesertaFasa 1/2
- NEXT Oncology, Fairfax · 11 mi jauh
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Mengambil pesertaFasa 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi jauh
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Mengambil pesertaFasa 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Mengambil pesertaFasa 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Next Oncology Virginia, Fairfax · 11 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Mengambil pesertaFasa 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi jauh
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Inova Schar Cancer Institute, Falls Church · 4 mi jauh
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site, Fairfax · 11 mi jauh
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Mengambil pesertaFasa 1
- Normunity Investigational Site, Fairfax · 11 mi jauh
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology - Virginia, Fairfax · 11 mi jauh
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Mengambil peserta
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Clinical Trial Site, Fairfax · 11 mi jauh
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 522, Fairfax · 11 mi jauh
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauh
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Fairfax · 11 mi jauh
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Mengambil pesertaFasa 1
- Dren Investigational Site, Fairfax · 11 mi jauh
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi jauh
Kajian Kanser Ovari di bandar lain
- Houston, TX89 kajian
- New York City, NY69 kajian
- Boston, MA61 kajian
- Los Angeles, CA50 kajian
- Nashville, TN49 kajian
- Philadelphia, PA44 kajian
- Columbus, OH39 kajian
- St. Louis, MO38 kajian
- Chicago, IL36 kajian
- San Antonio, TX31 kajian
- Cleveland, OH30 kajian
- Pittsburgh, PA30 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
- Kanser Perut20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.